ArticleJournal of the American College of Surgeons2012

Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.

Mark P Rubinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.